Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debut
Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...
Half of Americans Support Weight-Loss Drugs Like Ozempic for Obesity, Poll
Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...
About Half of Americans Approve of Using Weight-Loss Drugs to Treat Obesity, AP-NORC Poll Finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...
The high cost of weight loss: How patients are fighting for access to breakthrough medications
CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
How Many Steps a Day Help You Lose Weight?
But how much walking do you really need to do to lose weight? It would be great if there were a set number. Then you could ...
Hosted on MSN21h
Premier Weight Loss offers affordable weight loss solutions with expert guidance
The rise of popular weight-loss medications like Ozempic, Wegovy and Manjaro has sparked a new revolution in weight-loss solutions. However, the challenge lies in finding a trusted, affordable and ...
Why Weight-Loss Drugs Could Be Game-Changers for Your Investment Portfolio
Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.
NBC4 Columbus16h
Weight loss tech and techniques
Sponsor:  Columbus Weight Management Every year, millions of Americans set a New Year’s resolution to lose weight—only to ...
Weight-loss drug developer Metsera raises $275 million in US IPO
Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...